Fund to focus on its pioneering ‘asset-centric’ investment model, backing visionary biopharma entrepreneurs and drug hunters along the full drug development spectrum LONDON, GENEVA, ST HELIER, Jersey, July 27, 2023 /PRNewswire/ — Medicxi, a leading European life sciences investment firm,…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.